Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo
about
Leucoreduction of blood components: an effective way to increase blood safety?The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia.Classic and alternative red blood cell storage strategies: seven years of "-omics" investigations.The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration.An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies.Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.Peculiarities of studying the effects of pathogen reduction technologies on platelets.Non-polar lipids accumulate during storage of transfusion products and do not contribute to the onset of transfusion-related acute lung injury.Supernatants and lipids from stored red blood cells activate pulmonary microvascular endothelium through the BLT2 receptor and protein kinase C activation.Transfusion-related acute lung injury: three decades of progress but miles to go before we sleep.Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.Bioactive lipids accumulate in stored red blood cells despite leukoreduction: a targeted metabolomics study.Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology.
P2860
Q26771857-92B16C80-F0B1-4E74-8986-5F52B6AC804BQ33420150-B720F9C4-4883-460D-8810-6B1CBE226165Q35049133-94EDFF33-D657-4F13-936C-F5F73054FD7FQ37679818-74D240A2-F188-4D88-81F3-6D1F402FC02DQ38240578-D6EA148F-4623-42D2-AFF0-FE18946EA79EQ38447155-CD13BF27-5577-4CA1-B35D-B0FFD3A29117Q38812483-4F045905-68CC-42F7-A046-02AEE95A8990Q47340996-68BC9993-9843-4F68-9398-438E045744BDQ47705743-4C5D99D3-1587-462C-A97A-8C1C3C48C63FQ47974059-B17E9A63-2459-462E-BD95-5A8CF31D8DB3Q49408761-88456508-708E-411F-A31C-C12D6E5E1D7FQ50231259-7E4B7062-B1AB-4169-8018-5AB22FD36971Q50265769-B12FF541-01BF-4815-8E81-A72E89AC43EB
P2860
Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@ast
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@en
type
label
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@ast
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@en
prefLabel
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@ast
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@en
P2093
P2860
P1433
P1476
Experimental prestorage filtra ...... tants mitigating TRALI in vivo
@en
P2093
Barbara Mish
Christopher C Silliman
F Bernadette West
Kevin J Land
Linda Ceriano
Marguerite R Kelher
Monica LaSarre
Samina Y Khan
Samuel Sowemimo-Coker
P2860
P304
P356
10.1182/BLOOD-2013-10-532424
P407
P577
2014-04-18T00:00:00Z